{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T05:27:40Z","timestamp":1731043660950,"version":"3.28.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.hlc.2024.05.006","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T03:36:01Z","timestamp":1719977761000},"page":"1533-1542","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intracoronary Versus Intravenous Low-Dose Tirofiban in Patients With ST-Elevation Myocardial Infarction: A Meta-Analysis of Randomised Controlled Trials"],"prefix":"10.1016","volume":"33","author":[{"given":"Liye","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.hlc.2024.05.006_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"issue":"47","key":"10.1016\/j.hlc.2024.05.006_bib2","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","article-title":"Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials","volume":"38","author":"de Waha","year":"2017","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hlc.2024.05.006_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2009.03.054","article-title":"Myocardial no-reflow in humans","volume":"54","author":"Niccoli","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hlc.2024.05.006_bib4","first-page":"139","article-title":"Risk factors for no-reflow phenomenon after percutaneous coronary intervention in patients with acute coronary syndrome","volume":"69","author":"Liang","year":"2017","journal-title":"Rev Invest Clin"},{"issue":"2","key":"10.1016\/j.hlc.2024.05.006_bib5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jacc.2004.02.059","article-title":"Ability of anti-glycoprotein IIb\/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions","volume":"44","author":"Goto","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hlc.2024.05.006_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijcard.2010.08.027","article-title":"Aborted myocardial infarction in intracoronary compared with standard intravenous abciximab administration in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction","volume":"153","author":"Eitel","year":"2011","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.hlc.2024.05.006_bib7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/CIRCULATIONAHA.109.882746","volume":"121","author":"Deibele","year":"2010","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hlc.2024.05.006_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15842","article-title":"Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials","volume":"9","author":"Tian","year":"2023","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.hlc.2024.05.006_bib9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.hlc.2024.05.006_bib10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000051263","article-title":"Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials","volume":"12","author":"Oremus","year":"2001","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.hlc.2024.05.006_bib11","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.hlc.2024.05.006_bib12","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"7","key":"10.1016\/j.hlc.2024.05.006_bib13","first-page":"547","article-title":"Comparison of intracoronary versus intravenous tirofiban in acute ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention","volume":"33","author":"Tang","year":"2022","journal-title":"Coron Artery Dis"},{"issue":"1","key":"10.1016\/j.hlc.2024.05.006_bib14","first-page":"172","article-title":"Application of tirofiban in patients with acute myocardial infarction complicated with diabetes and undergoing emergency interventional therapy","volume":"38","author":"Tang","year":"2022","journal-title":"Pakistan J Med Sci"},{"issue":"3","key":"10.1016\/j.hlc.2024.05.006_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00059-018-4716-0","article-title":"Myocardial reperfusion with tirofiban injection via aspiration catheter: efficacy and safety in STEMI patients with large thrombus burden","volume":"45","author":"Zhang","year":"2020","journal-title":"Herz"},{"issue":"6","key":"10.1016\/j.hlc.2024.05.006_bib16","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s10554-020-01800-0","article-title":"Intracoronary compared with intravenous bolus tirofiban on the microvascular obstruction in patients with STEMI undergoing PCI: a cardiac MR study","volume":"36","author":"Ma","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.hlc.2024.05.006_bib17","first-page":"482","article-title":"Effect of intracoronary tirofiban bolus administration on platelet-derived microparticles and short-term clinical benefit in patients with acute ST-segment elevation myocardial infarction","volume":"35","author":"Li","year":"2016","journal-title":"Chin J Geriatr"},{"issue":"23","key":"10.1016\/j.hlc.2024.05.006_bib18","first-page":"3690","article-title":"Safety and efficacy of intracoronary tirofiban administration in patients with serious thrombus burden and ST-elevation myocardial infarction undergoing percutaneous coronary intervention","volume":"18","author":"Wang","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.hlc.2024.05.006_bib19","first-page":"117","article-title":"Effect of intracoronary tirofiban in patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention","volume":"30","author":"Zhou","year":"2014","journal-title":"J\u00a0Clinical Cardiol"},{"issue":"3","key":"10.1016\/j.hlc.2024.05.006_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ijcard.2011.08.082","article-title":"Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the ICT-AMI study","volume":"165","author":"Zhu","year":"2013","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.hlc.2024.05.006_bib21","first-page":"877","article-title":"Thrombus aspiration plus intra-infarct-related artery administration of tirofiban improves myocardial perfusion during primary angioplasty for acute myocardial infarction","volume":"123","author":"Yan","year":"2010","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"10.1016\/j.hlc.2024.05.006_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3724\/SP.J.1008.2009.00178","article-title":"Efficacy and safety of intravenous combined with intracoronary administration of tirofiban bolus in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"30","author":"Lu","year":"2009","journal-title":"Acad J Second Mil Med Univ"},{"issue":"6","key":"10.1016\/j.hlc.2024.05.006_bib23","first-page":"517","article-title":"Effects of intracoronary or intravenous tirofiban administration in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"35","author":"Yang","year":"2007","journal-title":"Zhonghua xin xue guan bing za zhi"},{"issue":"5","key":"10.1016\/j.hlc.2024.05.006_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5830\/CVJA-2019-027","article-title":"Clinical outcome of intracoronary versus intravenous high-dose bolus administration of tirofiban in diabetic patients undergoing primary percutaneous coronary intervention","volume":"30","author":"Ghonim","year":"2019","journal-title":"Cardiovasc J Africa"},{"issue":"1","key":"10.1016\/j.hlc.2024.05.006_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ccd.23109","article-title":"Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"79","author":"K\u0131rma","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"issue":"25","key":"10.1016\/j.hlc.2024.05.006_bib26","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.hlc.2024.05.006_bib27","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia-reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"10.1016\/j.hlc.2024.05.006_bib28","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/cvr\/cvy286","article-title":"The coronary circulation in acute myocardial ischaemia\/reperfusion injury: a target for cardioprotection","volume":"115","author":"Hausenloy","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.hlc.2024.05.006_bib29","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4244\/EIJV6I3A56","article-title":"Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial","volume":"6","author":"Timmer","year":"2010","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.hlc.2024.05.006_bib30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/0003319712474336","article-title":"No-reflow phenomenon: pathophysiology, diagnosis, prevention, and treatment. A review of the current literature and future perspectives","volume":"65","author":"Galasso","year":"2014","journal-title":"Angiology"},{"issue":"2","key":"10.1016\/j.hlc.2024.05.006_bib31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jacc.2003.08.040","article-title":"Effects of glycoprotein IIb\/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study","volume":"43","author":"Kunichika","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.hlc.2024.05.006_bib32","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM200106213442502","article-title":"Comparison of two platelet glycoprotein IIb\/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization","volume":"344","author":"Topol","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2024.05.006_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2018.05.014","article-title":"Protein kinases are involved in the cardioprotective effects activated by platelet glycoprotein IIb\/IIIa inhibitor tirofiban at reperfusion in rats in\u00a0vivo","volume":"832","author":"Chang","year":"2018","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.1016\/j.hlc.2024.05.006_bib34","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.cjca.2019.05.003","article-title":"Routine glycoprotein IIb\/IIIa inhibitor therapy in ST-segment elevation myocardial infarction: a meta-analysis","volume":"35","author":"Karathanos","year":"2019","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1016\/j.hlc.2024.05.006_bib35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2174\/1389200217666151211121112","article-title":"Effects of glycoprotein IIb\/IIIa antagonists: anti platelet aggregation and beyond","volume":"17","author":"Giordano","year":"2016","journal-title":"Curr Drug Metab"},{"issue":"2","key":"10.1016\/j.hlc.2024.05.006_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/CIRCRESAHA.119.315344","article-title":"Optimized treatment of ST-elevation myocardial infarction","volume":"125","author":"Niccoli","year":"2019","journal-title":"Circ Res"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950624006280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950624006280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T20:08:56Z","timestamp":1731010136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950624006280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1443950624006280"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2024.05.006","relation":{},"ISSN":["1443-9506"],"issn-type":[{"type":"print","value":"1443-9506"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracoronary Versus Intravenous Low-Dose Tirofiban in Patients With ST-Elevation Myocardial Infarction: A Meta-Analysis of Randomised Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2024.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}